PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage.
作者信息
Herrero-Beaumont G, Egido J
出版信息
Ann Rheum Dis. 1997 Apr;56(4):211-3. doi: 10.1136/ard.56.4.211.
Abstract
摘要
相似文献
1
PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage.
Ann Rheum Dis. 1997 Apr;56(4):211-3. doi: 10.1136/ard.56.4.211.
2
Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion.
J Cell Biol. 1990 Feb;110(2):529-40. doi: 10.1083/jcb.110.2.529.
3
[Platelet activating factor (PAF) and Lyme disease].
Nihon Saikingaku Zasshi. 1996 Aug;51(3):863-9. doi: 10.3412/jsb.51.863.
4
The role of platelet-activating factor in endothelial cells.
Thromb Haemost. 1990 Aug 13;64(1):99-103.
5
Effect of platelet activating factor on leukocyte-endothelial cell interactions.
Thromb Res. 1988 Jul 1;51(1):83-96. doi: 10.1016/0049-3848(88)90285-x.
6
7
Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.
Scand J Rheumatol. 1992;21(4):161-4. doi: 10.3109/03009749209099215.
8
PAF, cytokines, toxic oxygen products and cell injury.
Mol Aspects Med. 1991;12(2):169-74. doi: 10.1016/0098-2997(91)90012-b.
9
Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet activating factor and P-selectin.
Circulation. 1996 Jun 15;93(12):2152-60. doi: 10.1161/01.cir.93.12.2152.
10
Conversion of platelets from a proaggregatory to a proinflammatory adhesive phenotype: role of PAF in spatially regulating neutrophil adhesion and spreading.
Blood. 2007 Sep 15;110(6):1879-86. doi: 10.1182/blood-2006-08-040980. Epub 2007 Jun 4.
引用本文的文献
1
Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells.
Clin Exp Immunol. 1998 Mar;111(3):588-96. doi: 10.1046/j.1365-2249.1998.00530.x.
本文引用的文献
1
Adhesion and signaling in vascular cell--cell interactions.
J Clin Invest. 1996 Oct 15;98(8):1699-702. doi: 10.1172/JCI118967.
2
Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis.
J Lipid Mediat Cell Signal. 1996 Jan;13(1):35-49. doi: 10.1016/0929-7855(95)00043-7.
3
4
Lipid mediator networks in cell signaling: update and impact of cytokines.
FASEB J. 1996 Aug;10(10):1147-58. doi: 10.1096/fasebj.10.10.8751717.
5
Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor.
J Exp Med. 1996 Jul 1;184(1):191-201. doi: 10.1084/jem.184.1.191.
6
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase.
J Clin Invest. 1996 Jun 15;97(12):2784-91. doi: 10.1172/JCI118733.
7
Chemotactic factors stimulate CD18-dependent canine neutrophil adherence and motility on lung fibroblasts.
J Immunol. 1996 May 1;156(9):3389-401.
8
Treatment of rheumatoid arthritis with platelet activating factor antagonist BN 50730.
J Rheumatol. 1995 Sep;22(9):1651-4.
9
Platelet-activating factor stimulates resorption by rabbit osteoclasts in vitro.
Am J Physiol. 1993 Jan;264(1 Pt 1):E74-81. doi: 10.1152/ajpendo.1993.264.1.E74.
10
Platelet-activating factor induces collagenase expression in corneal epithelial cells.
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8678-82. doi: 10.1073/pnas.90.18.8678.
Zotero 插件